Trial ID or NCT#

NCT02389959

Status

RECRUITING

Purpose

This is a randomized, controlled, double-blind, placebo-controlled trial of intranasal Avastin (bevacizumab) injection versus saline control for control of HHT-related epistaxis when used in conjunction with bipolar electrocautery.

Official Title

Intranasal Bevacizumab for HHT-Related Epistaxis

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Peter H. Hwang
Rhinologist, Otolaryngologist
Professor of Otolaryngology - Head and Neck Surgery (Rhinology) and, by courtesy, of Neurosurgery at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Amelia K Clark, MD